Effects of triple antioxidant therapy on measures of cardiovascular autonomic neuropathy and on myocardial blood flow in type 1 diabetes: a randomised controlled trial
Rodica Pop‐Busui(University of Michigan), Eva L. Feldman(University of Michigan), Elizabeth White(Rutgers, The State University of New Jersey), Marc B. Brown(University of Michigan), Martin J. Stevens(Birmingham City University), David M. Raffel(University of Michigan), Mitali Mehta(University of Michigan), Cynthia Plunkett(University of Michigan)
Cited by 59
Related Papers
Amyotrophic lateral sclerosis
|The Lancet|2022|990
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin
|JAMA|2021|491
American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update
|Endocrine Practice|2022|465
Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments
|The Lancet Neurology|2022|333
Diabetic neuropathy and oxidative stress
|Diabetes/Metabolism Research and Reviews|2006|286